A challenging case of aggressive composite hemangioendothelioma with neuroendocrine differentiation and PTBP1::MAML2 fusion

Genes Chromosomes Cancer. 2024 Jun;63(6):e23245. doi: 10.1002/gcc.23245.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cell Differentiation / genetics
  • DNA-Binding Proteins / genetics
  • Female
  • Hemangioendothelioma* / genetics
  • Hemangioendothelioma* / pathology
  • Heterogeneous-Nuclear Ribonucleoproteins / genetics
  • Humans
  • Male
  • Oncogene Proteins, Fusion* / genetics
  • Polypyrimidine Tract-Binding Protein / genetics
  • Polypyrimidine Tract-Binding Protein / metabolism
  • Trans-Activators* / genetics
  • Transcription Factors / genetics

Substances

  • MAML2 protein, human
  • Trans-Activators
  • Oncogene Proteins, Fusion
  • Polypyrimidine Tract-Binding Protein
  • Heterogeneous-Nuclear Ribonucleoproteins
  • Transcription Factors
  • DNA-Binding Proteins